EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, MARCH 3, 2020
Media advisory: The full study and related articles are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.1012?guestAccessKey=436c5e49-870b-46ae-b1f5-250603900c85&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030320
What The Study Did: This study describes changes in list and net prices for 600 branded drugs in the U.S. from 2007 to 2018 and estimated the extent to which price increases were offset by increases in discounts. This study is part of a theme issue from JAMA on drug pricing.
Authors: Inmaculada Hernandez, Pharm.D., Ph.D. of the University of Pittsburgh School of Pharmacy, is the corresponding author.
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.